EUVIMEDEUVIMED entdecken
VergleichsstudieQuerschnittstudieOpen Access

Regulatory Readiness for Paper Replacement in Global Pharmaceutical Electronic Labeling: Cross-Sectional Comparative Policy Analysis

Da Eun Lee iD, Ji Sun Chun iD, Mari Kim iD, In-Wha Kim iD, Jung Mi Oh iD

Journal of Medical Internet Research · 18.08.2026 · 28 · e96787

DOI: 10.2196/96787 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Medical Internet Research, online erschienen am 18.08.2026. Verfasst von Da Eun Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Seoul National University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Drug Labeling. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Accurate and up-to-date medicinal product information is essential for the safe and effective use of medicines. Electronic labeling (e-labeling) has emerged as a potential alternative to paper-based package inserts by enabling timely updates, improving accessibility, and supporting integration with digital health systems. However, regulatory approaches to pharmaceutical e-labeling remain fragmented across jurisdictions.

Objective

This study examined how e-labeling policies have developed across International Coalition of Medicines Regulatory Authorities (ICMRA) member jurisdictions and explored the conditions associated with policies that position e-labeling as a replacement for paper-based product information.

Methods

We conducted a cross-sectional comparative policy analysis of publicly available national regulatory documents on pharmaceutical e-labeling issued between January 1, 2012, and May 31, 2026. The analysis focused on how regulatory intent, legal authority, implementation mechanisms, and replacement pathways were articulated in official policy documents across jurisdictions. A main corpus of official jurisdictional policy documents was supplemented by a triangulation corpus of international stakeholder documents. Hybrid thematic analysis and content analysis were used to identify and compare policy themes across jurisdictions. A 4-level e-labeling regulatory maturity framework was developed using 3 indicators: implementation status, level of authority, and expansion toward advanced considerations. Fuzzy-set qualitative comparative analysis (fsQCA) was then conducted across 19 jurisdictions to identify configurational patterns associated with paper-label replacement.

Results

A total of 81 policy documents from 20 jurisdictions were included in the main analysis, and 27 documents were included in the triangulation corpus. Nine themes were identified across 3 domains: e-labeling scope and implementation strategy, operational infrastructure, and advanced considerations. Most policies addressed target product information, medicine categories, transition approaches, interface mechanisms, and responsible entities. In contrast, structured digital formats, interoperability, and personalized information were less consistently addressed. The maturity assessment showed substantial variation across jurisdictions. Brazil and the Netherlands were classified at the highest maturity level, reflecting implementation with a legal basis and expansion toward advanced functions. The fsQCA identified 1 conservative sufficient configuration associated with paper-label replacement: digital infrastructure readiness, high e-labeling policy maturity, and explicit responsibility of the marketing authorization holder.

Conclusions

Pharmaceutical e-labeling has moved beyond early policy discussion in many ICMRA member jurisdictions, but regulatory maturity remains uneven. While most jurisdictions enable electronic access to product information, relatively few have established the legal and operational foundations to replace paper labeling. Paper-label replacement was associated with mature regulatory frameworks and clear operational responsibility. By combining a cross-jurisdictional regulatory maturity framework with fsQCA, this study provides a novel comparative approach that extends beyond previous descriptive studies by identifying the conditions associated with paper-label replacement. The proposed framework may offer a structured approach to assessing regulatory readiness and prioritizing the efforts required for effective legal development and implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug LabelingCross-Sectional StudiesHumans

Stichwörter der Autor:innen

MeSHdigital healthdrug labelingelectronic labelinghealth information systemshealth policypharmaceutical preparationspolicy analysisregulatory framework

Autor:innen und Institutionen

  • College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
  • Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
  • Natural Products Research Institute, Seoul National University, Seoul, Republic of Korea.

ORCID-Profile: Da Eun Lee, Ji Sun Chun, Mari Kim, In-Wha Kim, Jung Mi Oh

Zitieren

APA

Lee, D. E., Chun, J. S., Kim, M., Kim, I. W., & Oh, J. M. (2026). Regulatory Readiness for Paper Replacement in Global Pharmaceutical Electronic Labeling: Cross-Sectional Comparative Policy Analysis. Journal of Medical Internet Research, 28, e96787. https://doi.org/10.2196/96787

Vancouver

Lee DE, Chun JS, Kim M, Kim IW, Oh JM. Regulatory Readiness for Paper Replacement in Global Pharmaceutical Electronic Labeling: Cross-Sectional Comparative Policy Analysis. Journal of Medical Internet Research. 2026;28:e96787. doi:10.2196/96787

BibTeX
@article{Lee2026,
  author = {Lee, Da Eun and Chun, Ji Sun and Kim, Mari and Kim, In-Wha and Oh, Jung Mi},
  title = {Regulatory Readiness for Paper Replacement in Global Pharmaceutical Electronic Labeling: Cross-Sectional Comparative Policy Analysis},
  journal = {Journal of Medical Internet Research},
  year = {2026},
  volume = {28},
  pages = {e96787},
  doi = {10.2196/96787}
}
Kostenlos starten →